Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (abre una nueva ventana)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Fuente‎: J Bone Joint Surg Am 2013;95(21):1969-74.

Indexado en‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (abre una nueva ventana)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (abre una nueva ventana)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Fuente‎: J Bone Joint Surg Am 2013;95(21):1961-8.

Indexado en‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (abre una nueva ventana)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (abre una nueva ventana)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Fuente‎: Ann Surg 2019;269(5):794-804.

Indexado en‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (abre una nueva ventana)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (abre una nueva ventana)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Fuente‎: Spine 2009;34(19):2096-103.

Indexado en‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (abre una nueva ventana)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (abre una nueva ventana)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

Fuente‎: J Orthop Surg 2017;25(1):2309499016684725.

Indexado en‎: PubMed 28176599

DOI‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (abre una nueva ventana)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (abre una nueva ventana)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Fuente‎: J Arthroplasty 2013;28(8 Suppl):74-7.

Indexado en‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (abre una nueva ventana)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (abre una nueva ventana)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Fuente‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Indexado en‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (abre una nueva ventana)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (abre una nueva ventana)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Fuente‎: J Knee Surg 2017;30(5):460-6.

Indexado en‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (abre una nueva ventana)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (abre una nueva ventana)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Fuente‎: J Arthroplasty 2017;32(8):2375-80.

Indexado en‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (abre una nueva ventana)

Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (abre una nueva ventana)

DiBlasi JF, Smith RP, Garavaglia J, Quedado J, Frye BM, Dietz MJ.

Fuente‎: Am J Orthop 2016;45(7):E439-43.

Indexado en‎: PubMed 28005108

https://www.ncbi.nlm.nih.gov/pubmed/28005108 (abre una nueva ventana)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (abre una nueva ventana)

Dobosz B, Dutka J, Dutka L, Maleta P.

Fuente‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

Indexado en‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (abre una nueva ventana)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (abre una nueva ventana)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Fuente‎: Spine J 2017;17(7):977-82.

Indexado en‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (abre una nueva ventana)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (abre una nueva ventana)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Fuente‎: Orthop Clin North Am 2017;48(2):109-15.

Indexado en‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (abre una nueva ventana)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (abre una nueva ventana)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Fuente‎: Ir Med J 2018;111(4):730.

Indexado en‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (abre una nueva ventana)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (abre una nueva ventana)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

Fuente‎: Anesth Analg 2022;135(3):576-85.

Indexado en‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (abre una nueva ventana)

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (abre una nueva ventana)

Frank SM, Wasey JO, Dwyer IM, Gokaslan ZL, Ness PM, Kebaish KM.

Fuente‎: J Orthop Surg Res 2014;9:50.

Indexado en‎: PubMed 24997589

DOI‎: 10.1186/s13018-014-0050-2

https://www.ncbi.nlm.nih.gov/pubmed/24997589 (abre una nueva ventana)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (abre una nueva ventana)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Fuente‎: J Shoulder Elbow Surg 2016;25(4):614-8.

Indexado en‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (abre una nueva ventana)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (abre una nueva ventana)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Fuente‎: Transfusion 2017;57(2):357-66.

Indexado en‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (abre una nueva ventana)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (abre una nueva ventana)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

Fuente‎: J Arthroplasty 2013;28(8 Suppl):137-9.

Indexado en‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (abre una nueva ventana)

Cell saver for adult spinal deformity surgery reduces cost. (abre una nueva ventana)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Fuente‎: Spine Deform 2017;5(4):272-6.

Indexado en‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (abre una nueva ventana)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (abre una nueva ventana)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Fuente‎: J Am Acad Orthop Surg 2021;29(22):961-9.

Indexado en‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (abre una nueva ventana)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (abre una nueva ventana)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Fuente‎: Orthopedics 2017;40(6):e1044-9.

Indexado en‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (abre una nueva ventana)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (abre una nueva ventana)

Harris RN, Moskal JT, Capps SG.

Fuente‎: J Arthroplasty 2015;30(2):192-5.

Indexado en‎: PubMed 25534861

DOI‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (abre una nueva ventana)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (abre una nueva ventana)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Fuente‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indexado en‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (abre una nueva ventana)

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (abre una nueva ventana)

Karayiannis PN, Agus A, Bryce L, Hill JC, Beverland D.

Fuente‎: Bone Jt Open 2022;3(7):536-42.

Indexado en‎: PubMed 35816170

DOI‎: 10.1302/2633-1462.37.BJO-2021-0213.R1

https://www.ncbi.nlm.nih.gov/pubmed/35816170 (abre una nueva ventana)

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (abre una nueva ventana)

Kotzé A, Carter LA, Scally AJ.

Fuente‎: Br J Anaesth 2012;108(6):943-52.

Indexado en‎: PubMed 22593128

DOI‎: 10.1093/bja/aes135

https://www.ncbi.nlm.nih.gov/pubmed/22593128 (abre una nueva ventana)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (abre una nueva ventana)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Fuente‎: Transfusion 2017;57(6):1347-58.

Indexado en‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (abre una nueva ventana)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (abre una nueva ventana)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

Fuente‎: Br J Anaesth 2007;99(6):794-800.

Indexado en‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (abre una nueva ventana)

A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (abre una nueva ventana)

Mehra A, Murray J, DeAlwis C.

Fuente‎: Ann R Coll Surg Engl 2004;86(4):260-2.

Indexado en‎: PubMed 15239867

DOI‎: 10.1308/147870804551

https://www.ncbi.nlm.nih.gov/pubmed/15239867 (abre una nueva ventana)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (abre una nueva ventana)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

Fuente‎: J Arthroplasty 2018;33(6):1705-12.

Indexado en‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (abre una nueva ventana)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (abre una nueva ventana)

Moskal JT, Harris RN, Capps SG.

Fuente‎: J Arthroplasty 2015;30(3):365-8.

Indexado en‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (abre una nueva ventana)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (abre una nueva ventana)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

Fuente‎: Blood Transfus 2013;11(2):260-71.

Indexado en‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (abre una nueva ventana)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (abre una nueva ventana)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Fuente‎: Blood Transfus 2014;12(1):40-9.

Indexado en‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (abre una nueva ventana)

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. (abre una nueva ventana)

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

Fuente‎: Transfusion 2011;51(1):118-24.

Indexado en‎: PubMed 20624257

DOI‎: 10.1111/j.1537-2995.2010.02783.x

https://www.ncbi.nlm.nih.gov/pubmed/20624257 (abre una nueva ventana)

Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. (abre una nueva ventana)

Nichols CI, Vose JG.

Fuente‎: J Arthroplasty 2016;31(3):583-589.e1.

Indexado en‎: PubMed 26699673

DOI‎: 10.1016/j.arth.2015.10.013

https://www.ncbi.nlm.nih.gov/pubmed/26699673 (abre una nueva ventana)

The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (abre una nueva ventana)

Örs Ç, Çaylak R.

Fuente‎: Acta Orthop Traumatol Turc 2021;55(5):422-7.

Indexado en‎: PubMed 34730529

DOI‎: 10.5152/j.aott.2021.20397

https://www.ncbi.nlm.nih.gov/pubmed/34730529 (abre una nueva ventana)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (abre una nueva ventana)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

Fuente‎: Open Orthop J 2011;5:44-8.

Indexado en‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (abre una nueva ventana)

ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (abre una nueva ventana)

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J.

Fuente‎: Anesth Analg 2022;135(3):448-58.

Indexado en‎: PubMed 35977355

DOI‎: 10.1213/ANE.0000000000006065

https://www.ncbi.nlm.nih.gov/pubmed/35977355 (abre una nueva ventana)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (abre una nueva ventana)

Phan DL, Ani F, Schwarzkopf R.

Fuente‎: J Arthroplasty 2016;31(3):579-82.

Indexado en‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (abre una nueva ventana)

Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (abre una nueva ventana)

Pitta M, Zawadsky M, Verstraete R, Rubinstein A.

Fuente‎: Transfusion 2016;56(2):466-71.

Indexado en‎: PubMed 26509250

DOI‎: 10.1111/trf.13354

https://www.ncbi.nlm.nih.gov/pubmed/26509250 (abre una nueva ventana)

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (abre una nueva ventana)

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

Fuente‎: BMJ 2014;349:g4829.

Indexado en‎: PubMed 25116268

DOI‎: 10.1136/bmj.g4829

https://www.ncbi.nlm.nih.gov/pubmed/25116268 (abre una nueva ventana)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (abre una nueva ventana)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Fuente‎: Clin Orthop Relat Res 2010;468(7):1905-11.

Indexado en‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (abre una nueva ventana)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (abre una nueva ventana)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Fuente‎: J Arthroplasty 2018;33(7):2092-9.e9.

Indexado en‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (abre una nueva ventana)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (abre una nueva ventana)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

Fuente‎: Transfus Med 2009;19(4):202-6.

Indexado en‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (abre una nueva ventana)

Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (abre una nueva ventana)

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D'Amato T.

Fuente‎: Int Orthop 2019;43(1):39-46.

Indexado en‎: PubMed 30232527

DOI‎: 10.1007/s00264-018-4149-7

https://www.ncbi.nlm.nih.gov/pubmed/30232527 (abre una nueva ventana)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (abre una nueva ventana)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Fuente‎: Int Orthop 2019;43(12):2707-14.

Indexado en‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (abre una nueva ventana)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (abre una nueva ventana)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

Fuente‎: J Orthop Surg Res 2011;6:22.

Indexado en‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (abre una nueva ventana)

Increased hospital costs associated with red blood cell transfusion. (abre una nueva ventana)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Fuente‎: Transfusion 2015;55(5):1082-9.

Indexado en‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (abre una nueva ventana)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (abre una nueva ventana)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Fuente‎: J Arthroplasty 2014;29(8):1512-5.

Indexado en‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (abre una nueva ventana)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (abre una nueva ventana)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Fuente‎: J Arthroplasty 2020;35(11):3084-8.

Indexado en‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (abre una nueva ventana)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (abre una nueva ventana)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

Fuente‎: Thromb Res 2018;171:143-8.

Indexado en‎: PubMed 30312799

DOI‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (abre una nueva ventana)

Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (abre una nueva ventana)

Ye X, Lafuma A, Torreton E, Arnaud A.

Fuente‎: BMC Health Serv Res 2013;13:186.

Indexado en‎: PubMed 23692862

DOI‎: 10.1186/1472-6963-13-186

https://www.ncbi.nlm.nih.gov/pubmed/23692862 (abre una nueva ventana)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (abre una nueva ventana)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

Fuente‎: Int Orthop 2007;31(3):303-8.

Indexado en‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (abre una nueva ventana)

Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (abre una nueva ventana)

Zhu J, Zhu Y, Lei P, Zeng M, Su W, Hu Y.

Fuente‎: Medicine 2017;96(52):e9552.

Indexado en‎: PubMed 29384974

DOI‎: 10.1097/MD.0000000000009552

https://www.ncbi.nlm.nih.gov/pubmed/29384974 (abre una nueva ventana)